Recherche
-
Complement C3 mediates early hippocampal neurodegeneration and memory impairment in experimental multiple sclerosis.
(Neurobiology of Disease. vol. 160, pp. 105533, 2021-12-01)Article de revueLibre accès -
CB1 and GLP-1 Receptors Cross Talk Provides New Therapies for Obesity
(Diabetes. vol. 70, n° 2, pp. 415-422, 2021-02)Article de revue -
Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts
(CNS drugs. vol. 35, n° 11, pp. 1217-1232, 2021-11)Article de revue -
Identification of BiP as a CB1 receptor-interacting protein that fine-tunes cannabinoid signaling in the mouse brain
(Journal of Neuroscience. vol. 41, n° 38, pp. 7924-7941, 2021-09-22)Article de revueLibre accès -
Breathing-driven prefrontal oscillations regulate maintenance of conditioned-fear evoked freezing independently of initiation
(Nature Communications. vol. 12, n° 1, 2021-05-10)Article de revueLibre accès -
A meta-analysis comparing first-line immunosuppressants in neuromyelitis optica
(Annals of Clinical and Translational Neurology. vol. 8, n° 10, pp. 2025-2037, 2021-10)Article de revueLibre accès -
Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With Natalizumab
(Neurology. vol. 8, n° 4, 2021-04-26)Article de revueLibre accès -
The temporal origin of dentate granule neurons dictates their role in spatial memory
(Molecular Psychiatry, 2021-12)Article de revueLibre accès -
Nicotine inhibits the VTA-to-amygdala dopamine pathway to promote anxiety
(Neuron. vol. 109, n° 16, pp. 2604-2615.e9, 2021-08-18)Article de revueLibre accès -
French validation of the Brief International Cognitive Assessment for Multiple Sclerosis
(Revue Neurologique. vol. 177, n° 1-2, pp. 73-79, 2021-01)Article de revue